Selected article for: "known risk and low risk"

Author: Ali, Sadaf; Pappachan, Joseph M.; Mathew, Smitha
Title: Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 – should we prolong prophylactic anticoagulation?
  • Cord-id: j8e8gb0l
  • Document date: 2020_6_13
  • ID: j8e8gb0l
    Snippet: Abstract Severe corona virus disease 19 (Covid-19) is known to be associated with exaggerated risk of thromboembolism. However, the risk associated with mild and moderate illness from Covid-19 is unknown, and there is no current recommendation for prophylaxis against thromboembolism in patients after hospital treatment unless there are established thrombophilic risk factors. We report the case of a 52-year old woman, who presented with massive saddle pulmonary embolism after one week of initial
    Document: Abstract Severe corona virus disease 19 (Covid-19) is known to be associated with exaggerated risk of thromboembolism. However, the risk associated with mild and moderate illness from Covid-19 is unknown, and there is no current recommendation for prophylaxis against thromboembolism in patients after hospital treatment unless there are established thrombophilic risk factors. We report the case of a 52-year old woman, who presented with massive saddle pulmonary embolism after one week of initial hospital discharge, successfully thrombolysed that raises the question of consideration of extended prophylactic anticoagulation even in low risk Covid-19 cases.

    Search related documents:
    Co phrase search for related documents
    • activation inflammatory cytokine and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • activation inflammatory cytokine and lung infiltrate: 1
    • activation inflammatory cytokine and lymphocyte count: 1
    • acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute ards respiratory distress syndrome and lung infiltrate: 1
    • acute ards respiratory distress syndrome and lung window: 1, 2
    • acute ards respiratory distress syndrome and lupus anticoagulant: 1
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37